Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

ClinicalTrials.gov ID: NCT00613626

Public ClinicalTrials.gov record NCT00613626. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 12:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Double Blind Phase II Trial of Cisplatin Plus Etoposide With/Without Concurrent ZD6474 in Patients With Previously Untreated Extensive Stage Small Cell Lung Cancer: Hoosier Oncology Group LUN06-113

Study identification

NCT ID
NCT00613626
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Hoosier Cancer Research Network
Other
Enrollment
74 participants

Conditions and interventions

Interventions

  • Cisplatin Drug
  • Etoposide Drug
  • Placebo Drug
  • ZD6474 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2007
Primary completion
Jul 31, 2015
Completion
Jul 31, 2015
Last update posted
Feb 10, 2020

2008 – 2015

United States locations

U.S. sites
19
U.S. states
7
U.S. cities
16
Facility City State ZIP Site status
Helen F. Graham Cancer Center Newark Delaware 19713
Northwestern University Feinberg School of Medicine Chicago Illinois 60611
Medical & Surgical Specialists, LLC Galesburg Illinois 61401
Cancer Care Center of Southern Indiana Bloomington Indiana 47403
Oncology Hematology Associates of SW Indiana Evansville Indiana 47714
Fort Wayne Oncology & Hematology, Inc Fort Wayne Indiana 46815
IN Onc/Hem Associates Indianapolis Indiana 46202
Indiana University Simon Cancer Center Indianapolis Indiana 46202
St. Vincent Hospital & Health Centers Indianapolis Indiana 46206
IU Health Arnett Cancer Center Lafayette Indiana 47904
Horizon Oncology Researcg Lafayette Indiana 47905
IU Health at Ball Memorial Hospital Muncie Indiana 47303
Monroe Medical Associates Munster Indiana 46321
Northern Indiana Cancer Research Consortium South Bend Indiana 46601
Providence Medical Group Terre Haute Indiana 47802
Methodist Cancer Center Omaha Nebraska 68114
Hematology Oncology Associates S.J., P.A. Mount Holly New Jersey 08060
Providence Portland Medical Center Portland Oregon 97213
Pennsylvania Oncology-Hematology Associates Philadelphia Pennsylvania 19106

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00613626, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 10, 2020 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00613626 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →